AS2575959 (sodium) is an agonist of GPR40 . AS2575959 (sodium) can enhance glucose metabolism and has synergic effect with Sitagliptin ( HY-13749 ) on insulin as well as incretin secretion. AS2575959 (sodium) can be studied in research on type 2 diabetes.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Free Fatty Acid Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.